These data identified PKP4 as an important FMRP target and strongly suggest that impaired actin cytoskeletal functions mediated by an excess of PKP4 are a key aspect underlying the fragile X syndrome [40]. The gene discussed is PKP4; the disease is fragile X syndrome.